Biotech

Miraculins Announces Retail Pharmacy Pilot for Its Scout DS(R) Non-Invasive Diabetes Screening Technology

WINNIPEG, MANITOBA: First Scout DS(R) Diabetes Screening Kiosks to be Introduced in Ontario ...

ProMetic''s PBI-4050 Cleared to Commence Clinical Trials in Patients with Metabolic Syndrome and Associated Type 2 Diabetes

LAVAL, QUEBEC: - Clinical Trial Application ("CTA") clearance received from Health Canada - Enrollment of patients commencing in Q1 2015 ...

Corcept Therapeutics to Announce Fourth Quarter and Full Year 2014 Revenue and Corporate Update and Host Conference Call

MENLO PARK, CA: ...

MYOS Corporation''s Preclinical Study of Fortetropin''s(TM) Mechanism of Action Demonstrate Regulatory Effects on Three Key Muscle Health Pathways

CEDAR KNOLLS, NJ: ...

Cellceutix Phase 2b Clinical Trial of Brilacidin Accepted for Oral Presentation at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

BEVERLY, MA: Company to Give Three Presentations Highlighting Its Novel Antibiotics ...

Ceapro Raises $650,000 through a Non-Brokered Private Placement

EDMONTON, ALBERTA: ...

Health Canada Clears Immunovaccine to Conduct Phase I Clinical Trial of Respiratory Syncytial Virus (RSV) Vaccine

HALIFAX, NOVA SCOTIA: First Clinical Study in Infectious Disease Indication with a DepoVax(TM)-Based Vaccine ...

Miraculins Announces 2015 Plans for Its Scout DS® Non-Invasive Diabetes Screening Technology

WINNIPEG, MANITOBA: ...

Phase II Clinical Data of Peregrine Pharmaceuticals'' Bavituximab in Combination With Sorafenib Presented at ASCO Gastrointestinal Cancers Symposium

TUSTIN, CA: Positive Trends in Time to Progression, Disease Control Rates and 4-Month Progression-Free Survival Endpoints Were Reported in a Patient Population With Poor Prognosis; Survival Curves Showed Patients ...

Abattis Announces a Manufacturing Partnership With Empirical Labs of Ft. Collins, Colorado

VANCOUVER, BRITISH COLUMBIA: ...